Wen Chyi Shyu
Chief Executive Officer at BRIM Biotechnology, Inc.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Shimoga Prakash
Ever since Wen Chyi joined Millennium she has been able to steer the drug metabolism department in a direction that is highly conducive for oncology drug discovery and development. Her initiatives on modeling and simulation of cellular functions as well as on biophramaceutics are expected to assist oncology drug discovery and development in a significant way.
Shimoga Prakash
Ever since Wen Chyi joined Millennium she has been able to steer the drug metabolism department in a direction that is highly conducive for oncology drug discovery and development. Her initiatives on modeling and simulation of cellular functions as well as on biophramaceutics are expected to assist oncology drug discovery and development in a significant way.
Shimoga Prakash
Ever since Wen Chyi joined Millennium she has been able to steer the drug metabolism department in a direction that is highly conducive for oncology drug discovery and development. Her initiatives on modeling and simulation of cellular functions as well as on biophramaceutics are expected to assist oncology drug discovery and development in a significant way.
Shimoga Prakash
Ever since Wen Chyi joined Millennium she has been able to steer the drug metabolism department in a direction that is highly conducive for oncology drug discovery and development. Her initiatives on modeling and simulation of cellular functions as well as on biophramaceutics are expected to assist oncology drug discovery and development in a significant way.
Experience
-
BRIM Biotechnology, Inc.
-
Taiwan
-
Biotechnology Research
-
1 - 100 Employee
-
Chief Executive Officer
-
Feb 2023 - Present
-
-
-
Takeda Oncology
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Vice President
-
2010 - Present
Head of Global Drug Metabolism and Pharmacokinetics Head of Global Drug Metabolism and Pharmacokinetics
-
-
-
Takeda
-
Japan
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Head of R&D Global Drug Metabolism and Pharmacokinetics at Takeda
-
Jan 2010 - Feb 2023
-
-
-
Bristol Myers Squibb
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Group Director, Discovery Medicine and Clinical Pharmacology
-
May 2008 - Dec 2009
-
-
-
-
Group Director
-
1985 - 2009
-
-
-
Bristol Myers Squibb
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Group Director Matabolism and Pharmacokinetics
-
2002 - 2008
-
-
Education
-
1983 - 1985
University of Florida
Post Doc, Pharmacokinetics -
1979 - 1983
University of Connecticut
Ph.D, Pharmacetuics
Community
